Literature DB >> 26311864

Fluoroquinolone Resistance in Salmonella and the Utility of Pefloxacin Disk Diffusion [corrected].

Ferric C Fang1.   

Abstract

Fluoroquinolone resistance is a serious and increasingly common problem in Salmonella. Two companion studies in this issue of the Journal of Clinical Microbiology (E. Deak, R. Skov, J. A. Hindler, and R. M. Humphries, J Clin Microbiol 53:3405-3410, 2015, http://dx.doi.org/10.1128/JCM.01393-15; R. Skov, E. Matuschek, M. Sjölund-Karlsson, J. Åhman, A. Petersen, M. Stegger, M. Torpdahl, and G. Kahlmeter, J Clin Microbiol 53:3411-3417, 2015, http://dx.doi.org/10.1128/JCM.01287-15) provide data to support the use of pefloxacin disk diffusion as a convenient and inexpensive surrogate laboratory method to detect fluoroquinolone resistance in Salmonella when the direct measurement of fluoroquinolone MICs is not feasible [corrected]. Recently updated CLSI and EUCAST susceptibility breakpoints will help to optimize clinical outcomes and reduce the likelihood of emergent resistance.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26311864      PMCID： PMC4609675          DOI： 10.1128/JCM.02270-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  44 in total

1.  Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations.

Authors:  J Zhou; Y Dong; X Zhao; S Lee; A Amin; S Ramaswamy; J Domagala; J M Musser; K Drlica
Journal:  J Infect Dis       Date:  2000-07-24       Impact factor: 5.226

2.  Resistance to fluoroquinolones in Salmonella non-typhi and Campylobacter spp.

Authors:  J Reina
Journal:  Lancet       Date:  1992-10-24       Impact factor: 79.321

3.  Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.

Authors:  Ari Robicsek; Jacob Strahilevitz; George A Jacoby; Mark Macielag; Darren Abbanat; Chi Hye Park; Karen Bush; David C Hooper
Journal:  Nat Med       Date:  2005-12-20       Impact factor: 53.440

4.  Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India.

Authors:  S Joshi; S K Amarnath
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-09-06       Impact factor: 2.184

5.  Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment.

Authors:  J Wain; N T Hoa; N T Chinh; H Vinh; M J Everett; T S Diep; N P Day; T Solomon; N J White; L J Piddock; C M Parry
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

6.  International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries.

Authors:  Kees Veldman; Lina M Cavaco; Dik Mevius; Antonio Battisti; Alessia Franco; Nadine Botteldoorn; Mireille Bruneau; Agnès Perrin-Guyomard; Tomas Cerny; Cristina De Frutos Escobar; Beatriz Guerra; Andreas Schroeter; Montserrat Gutierrez; Katie Hopkins; Anna-Liisa Myllyniemi; Marianne Sunde; Dariusz Wasyl; Frank M Aarestrup
Journal:  J Antimicrob Chemother       Date:  2011-03-09       Impact factor: 5.790

7.  Emergence of plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates from humans in the United States.

Authors:  Maria Sjölund-Karlsson; Jason P Folster; Gary Pecic; Kevin Joyce; Felicita Medalla; Regan Rickert; Jean M Whichard
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

Review 8.  Plasmid-mediated quinolone resistance: a multifaceted threat.

Authors:  Jacob Strahilevitz; George A Jacoby; David C Hooper; Ari Robicsek
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

9.  Co-spread of oqxAB and blaCTX-M-9G in non-Typhi Salmonella enterica isolates mediated by ST2-IncHI2 plasmids.

Authors:  Liang Li; Xiao-Ping Liao; Zhen-Zhen Liu; Ting Huang; Xue Li; Jian Sun; Bao-Tao Liu; Qijing Zhang; Ya-Hong Liu
Journal:  Int J Antimicrob Agents       Date:  2014-06-27       Impact factor: 5.283

Review 10.  Declining susceptibilities of gram-negative bacteria to the fluoroquinolones: effects on pharmacokinetics, pharmacodynamics, and clinical outcomes.

Authors:  Matthew J Labreche; Christopher R Frei
Journal:  Am J Health Syst Pharm       Date:  2012-11-01       Impact factor: 2.637
View more
  3 in total

1.  Pefloxacin as a Surrogate Marker for Fluoroquinolone Susceptibility for Salmonella typhi: Problems and Prospects.

Authors:  Balaji Veeraraghavan; Shalini Anandan; Dhiviya Prabaa Muthuirulandi Sethuvel; Naveen Kumar Devanga Ragupathi
Journal:  J Clin Diagn Res       Date:  2016-08-01

2.  Molecular Characterization of Intermediate Susceptible Typhoidal Salmonella to Ciprofloxacin, and its Impact.

Authors:  Balaji Veeraraghavan; Shalini Anandan; Dhiviya Prabaa Muthuirulandi Sethuvel; Nivetha Puratchiveeran; Kamini Walia; Naveen Kumar Devanga Ragupathi
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

Review 3.  Fluoroquinolone resistance in Salmonella: insights by whole-genome sequencing.

Authors:  Wim L Cuypers; Jan Jacobs; Vanessa Wong; Elizabeth J Klemm; Stijn Deborggraeve; Sandra Van Puyvelde
Journal:  Microb Genom       Date:  2018-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.